Creative – savyapharmaa

Why India’s Pharmaceutical Industry Remains Poised for Growth in 2025

StandardMay 14, 20202KViews 2Likes 0Comments

India’s pharmaceutical industry, valued at around US$58 billion, is projected to reach US$120-130 billion by 2030 and US$400-450 billion by 2047. Growth is driven by rising lifestyle diseases, an aging population, increased focus on holistic health, and the growing consumerization of healthcare. India allows 100 percent FDI under automatic approval for greenfield investments and up to…

The rise and rise of the pharmaceutical supply chain in India

StandardMay 14, 20202KViews 0Likes 0Comments

Often hailed as the 'pharmacy of the world,' the Indian pharmaceutical industry is booming. It jumped from $40 billion in 2021 to an expected $130 billion in 2030, with projection hitting Beyond just keeping up with the demand at home, the Indian pharma industry commands over 20% of the global pharma supply chain and addresses…

5 Reasons for the growth of pharmaceutical businesses in India

StandardMay 14, 2020878Views 0Likes 0Comments

India is the world’s leading manufacturer of pharmaceutical products, with the industry ranking third in terms of volume. Because of its enormous contribution to the world, the industry is gaining more and more success these days.

5 Reasons behind the tremendous growth of the pharma sector

StandardMay 14, 2020959Views 1Like 0Comments

Manufacturing functionalized APIs Active Pharma Ingredients (APIs) are the raw materials that go into manufacturing medicines. APIs are those ingredients that facilitate the intended health effects of the medicine. Many leading companies that manufacture specialized APIs are renounced for their immense contribution to alleviating the Indian healthcare system. Thus, The Indian pharmaceutical industry has earned its…

Emerging from disruption: The future of pharma operations strategy

ManufactureApril 21, 20202KViews 1Like 0Comments

To maintain profitable and resilient operations, CEOs and COOs of pharma companies may need to make bold changes to their operations strategy as the industry navigates new challenges. many pharmaceutical companies (pharmacos) deprioritized operations strategy in the face of competing business pressures. This is now changing. Factors such as the COVID-19 pandemic, inflation, geopolitics, new therapeutic…